We present a strategy to image neuroinflammation in grey matter using diffusion-weighted MRI. We demonstrate that the MRI signal carries the fingerprint of microglia and astrocytes activation, and that specific signatures from each glia population can be extracted in vivo. In addition, we prove the translational value of the approach in a cohort of healthy humans. This framework will aid basic and clinical research to clarify the role of inflammation during lifespan.
Main

Introduction
Neurodegenerative diseases such as Alzheimer's, Parkinson's, multiple sclerosis and dementia are among the most pressing problems of developed societies with aging populations [1] [2] [3] . Accumulating evidence suggests chronic neuroinflammation, the sustained activation of microglia and astrocytes in the brain, to strongly influence neurodegeneration and contribute to its progression. In addition, abnormal immune activation during puberty and adolescence has been recognized to increase vulnerabilities to brain disorders later in life [4] , making the characterization of the inflammatory profile along the lifespan a hot topic. A major question is whether inhibition of the inflammatory response has the ability to reverse or slow down its symptoms [5] . Therapies targeting glial cells are currently being proposed as diseasealtering treatments to improve the outcome of neurological disorders, with extremely promising results [5] [6] [7] . Furthermore, for many brain diseases [8] , neuroinflammation is emerging as a cause, rather than a consequence of the pathogenesis, thus, characterizing the tissue inflammatory state could serve as valuable early disease biomarkers.
While imaging techniques are widely adopted to monitor neurologic conditions, non-invasive approaches able to specifically characterize brain inflammation in vivo are lacking. The current goldstandard is positron emission tomography (PET)-based targeting of the 18kDa translocator protein. While difficult to generalize due to different binding genotypes across individuals [9] , PET is associated with ionizing radiation exposure, which limits its use in vulnerable populations and longitudinal studies, and also has low spatial resolution, making it unsuitable to image small brain structures. Diffusion-weighted magnetic resonance imaging (DW-MRI), on the other hand, has the unique ability to image brain microstructure in vivo, non-invasively and with high resolution by capturing the random motion of water molecules in brain parenchyma [10] .
While the DW-MRI signal is potentially sensitive to all extracellular and intracellular spaces that define water restriction pools in the tissue, current formulations are mostly designed for white matter and axons. However, by combining advanced DW-MRI sequences, the neurobiological knowledge about brain parenchyma, and proper mathematical models, the diffusion characteristics within specific tissue compartments, and even cell types, could be measured.
With this idea in mind, we developed an innovative strategy to image microglia and astrocyte activation in grey matter using DW-MRI, by building a microstructural multi-compartment tissue model based on microglia and astrocyte morphology. To validate the model, we used an established rat paradigm of inflammation based on intracerebral lipopolysaccharide (LPS) administration [11] . In the initial stages of this paradigm, neuronal viability and morphology is preserved, while inducing a microglia activation within few hours, and delayed astrocytic response detectable only 24 hours after the injection [12] . Therefore, a glial response can be transiently dissociated from neuronal degeneration, and the signature of reactive microglia investigated independently of any astrogliosis. Furthermore, to isolate the imaging fingerprint of astrocytes activation, we repeated the experiment in rats previously treated with the CSF1R-inhibitor PLX5622 (Plexxikon Inc.), which is known to temporally deplete up to 90% of the microglia population [13] .
We demonstrate, for the first time, that DW-MRI signal carries the fingerprint of microglia and astrocytes activation, and that signatures specific to each glia population, reflecting the morphological changes as validated post-mortem by quantitative immunohistochemistry, can be extracted in vivo. In addition, we demonstrate the translational value of the approach in a cohort of healthy humans, in which we performed a reproducibility analysis. A framework able to characterize relevant aspects of tissue microstructure during inflammation in vivo and non-invasively, is expected to have a tremendous impact on our understanding of the pathophysiology of many brain conditions, and transform current diagnostic practice and treatment monitor strategies.
Results
We first built a model of grey matter diffusivity to account for water diffusion in a microglial compartment corresponding to small cell somas (modeled as small spheres) and thin cellular processes (modeled as sticks) growing radially from the soma with a certain dispersion, and an astrocytic compartment consisting on large globular cells (modeled as large spheres) [14] , both of them embedded in an extracellular space compartment, as detailed in the methods section. We then tested the mathematical model with an experimental paradigm of neuroinflammation, induced by an injection of LPS in one hemisphere (targeting the dentate gyrus of the hippocampus) and with the contralateral side as within-subjects control (vehicle injected, see methods for details).
Morphological analysis of Iba-1 + cells by histology in the tissue at different time-points after LPS injection demonstrate a fast microglial reaction with retraction of cellular processes at 8h, that progresses at 24 h with an additional increase in the microglial cell body size and a reduction in the processes dispersion, as shown in Fig. 1 b-c. The distinct and time-dependent changes in microglial cell morphology are tightly mirrored by the imaging parameters specifically related to the microglia compartment, i.e., the sticks (cellular processes) and the small spheres (cell soma). Accordingly, the stick fraction is significantly reduced at 8 hours in the injected hippocampus compared to the control side, and further reduced at 24 hours. The radius of the small sphere component is significantly increased at 8 and 24 hours. Importantly, these LPS-induced changes disappear when the animals are depleted of microglia by the pretreatment with PLX5622, demonstrating that the MRI signatures are specific to the microglia population. Moreover, when looking at inter-individual variability, a strong association was found between MRI-derived microglial markers and their histological counterparts at all measured time points ( Fig. 1e-f ). Finally, at 2 weeks post-injection, when complete recovery is expected, all parameters measured from both histology and MRI converge, showing no statistically significant difference between injected and control hemisphere. Overall, these results demonstrate the possibility to recover a microgliaspecific signal from DW-MRI with capacity to unmask a microglial reaction in vivo (Fig. 1g) .
We next performed a comparable analysis with astrocytes (labeled as GFAP + cells) taking advantage of the distinct time course of their response to LPS injection. This cell population, unlike microglia, shows no significant alteration neither in density nor morphology at 8h post LPS injection, as shown in Fig.2b and supplementary Fig 7. However, at 24h, astrocytes grow in volume as measured by the mean radius of the convex hull ( Fig. 2 , see methods for details). Interestingly, the associated MRI compartment for astrocytes, i.e. the large spheres, follows the same pattern of changes across conditions. Volume of GFAP + cells and the mean radius of the large spheres measured by DW-MRI grew in parallel at 24h post LPS injection, were insensitive to microglia depletion with PLX5622 pretreatment and recovered towards baseline levels at 15 days post-injection. Accordingly, their inter-individual variability showed a strong correlation ( Fig. 2d ). Therefore, the results obtained for the astrocytic component also demonstrate the possibility to recover an astrocyte-specific signal from DW-MRI with capacity to map an astrocyte reaction in vivo (Fig. 1g ).
To highlight the importance of the developed framework, it is important to show that conventional MRI is sensitive to morphological changes due to inflammation, but cannot disentangle the different populations involved across different conditions, as shown in Fig. S4 . An increase in mean diffusivity reflects mostly changes in the extra-cellular space. A clear reduction of T1/T2 is observed in all three conditions, while no myelin change is observed in histology ( Fig. S3 ). T2* does not have enough sensitivity to reflect glia morphological changes at any stages.
As a proof of concept for the translational validity of these results and to evaluate the reproducibility of the proposed imaging framework, we adapted the MRI protocol to a human 3T Connectom scanner [15] and acquired data from a healthy cohort. As shown in Fig. 3 , the multicompartment model applied to these data returned values for the coefficient of variations (CoV) withinsubjects in the range 1.5-8%, and CoV between-subjects in the range 2.6-15, which is in the range of conventional MRI measures routinely used in the clinics with diagnostic value. Finally, we took advantage of the known heterogeneous distribution of microglial cell densities across brain regions in humans to test the ability of our framework to quantify microglial cell populations in vivo. Importantly, we found that the stick fraction calculated across different grey matter regions follows the patterns of microglia cell density measured post mortem in humans [16] , with the hippocampus showing the largest volume fraction (Fig. S5 ).
Discussion
Diffusion MRI signal has great potential to reveal the inflammatory component in numerous brain conditions [17] , and several efforts have been made to provide microstructural models able to capture features belonging to distinct tissue sub-compartments, for example by including dendrites dispersion [18, 19] or a compartment for the soma of neurons [20] . However, so far, no framework was available to specifically look at the cellular signature of glia activation. Here we propose and validate a strategy to image microglia and astrocyte activation in grey matter using diffusion MRI, and demonstrate its translational validity to humans. By taking advantage of the different activation windows of glia in an LPS-driven immunological challenge in rats, and by using pharmacological tools to deplete microglia in the brain, we were able to dissect the MRI signatures of specific glial responses. We identified two MRI parameters, namely the stick fraction and the larger sphere size, as sensitive to, and only to, microglia and astrocyte activation, respectively.
Our results are supported by quantitative cell morphology analysis. Validation of MRI results is challenging due to several factors, including the need to co-register regions of interest with very different sizes and properties and the need for tissue fixation in the histological preparations [21] . To overcome this limitation, here we relied on measuring changes rather than absolute magnitude of quantities. We demonstrate that there is a very high correlation between the changes found in injected vs. control regions, as measured using MRI and histology, suggesting that our imaging measures truly capture the hallmark of glia activation with high sensitivity.
The proposed MRI methodology was adapted to a human MRI scanner, and healthy subjects were recruited to perform a reproducibility study, demonstrating that the glia biomarkers are highly reproducible between different MRI sessions and in line with CoVs calculated for conventional MRI parameters routinely used in clinical settings [22] .
Our results have implications in the interpretation of several imaging studies published so far.
We propose that since diffusion MRI signal is sensitive to glia activation, the biological substrate of some of the alterations reported in numerous brain conditions could be driven by changes in glia morphology, rather than the conventional interpretation as "neural damage or degeneration". For example, multiple sclerosis (MS) is known to have a strong inflammatory component [2] and while DW-MRI is widely applied to characterize brain damage in MS, current approaches cannot differentiate between glia activation and neuronal damage.
This study has some limitations. While the multicompartment model does not explicitly differentiate between microglia processes and dendrites, basic geometrical reasoning supports the idea that neuronal loss would increase the stick dispersion, rather than decreasing it, and would thus be easily distinguished from a microglia activation, although this claim needs to be proven in future studies.
To conclude, we proposed here a new generation of non-invasive glia-centric biomarkers, which are expected to transform the study of many diseases associated with a glial response: those where inflammation is as a known or possible cause, as well as those in which the glial reaction can serve as a powerful early diagnostic and/or prognostic marker. times (s1-s6) and pooling all subject together (red). The same is shown for the stick dispersion (b), small (c), large sphere radius (d), mean diffusivity (e) and fractional anisotropy (f). g, average coefficient of variation calculated within subject (light grey) and between subjects (striped). h, mean stick fraction map in the hippocampus averaged in the whole cohort. i, mean large sphere radius map in the hippocampus averaged in the whole cohort.
Online Methods
Animal preparation
All animal experiments were approved by the Animal Care and Use Committee of the Instituto (4) (5) , with 12-12h light/dark cycle, lights on at 8:00, at room temperature (23 ± 2ºC) and free access to food and water. Microglia activation was achieved by intracranial injection in the dorsal hippocampus (coordinates bregma -3.8 mm, sup-inf 3.0 mm, 2 mm from midline in the left hemisphere) of 2 μl of saline and LPS at concentration of 2.5 μg/μl. The opposite hemisphere was injected with the same amount of saline. In a cohort of animals, microglia depletion was achieved by administering the CSF1R-inhibitor PLX5622 (Plexxikon Inc.) in two ways: as a dietary supplement in standard chow at 1200 ppm (Research Diets), and with intraperitoneal injection of 50 mg/kg in vehicle once a day for 7 days. Another cohort of rats received the same chow without enrichment, and was injected IP once a day with the same doses of vehicle. Less than 24 hours after the last injection, all the rats were injected LPS according to the procedure described above.
After different post-injection delays, the rats were scanned in a Bruker 7T MRI scanner using a diffusion-weighted sequence and immediately perfused for ex-vivo MRI immunohistological analysis of microglia (Iba-1+) and astrocytes (GFAP+). A total of 27 rats were used, with weights in the range 250gr-300gr, divided in 5 groups. Group 1 (n=6) received the LPS injection, and was scanned and perfused after 8 hours. Group 2a (n=7) received the LPS injection and was scanned and perfused after 24 hours.
Group 2b (n=4) was treated with control chow and injected with vehicle for 7 days, then received the LPS injection and was scanned and perfused after 24 hours. Group 3 (n=6) was treated with PLX5622 for 7 days, then received the LPS injection and was scanned and perfused after 24 hours. Group 4 (n=6) received the LPS injection and was scanned and perfused after a minimum of 15 days, or more if the ventricular enlargement was not reabsorbed. No statistically significant differences were detected between group 2a and b (control for PLX5622 chow), so they were merged into a single group for the rest of the analysis. Experimental design is reported in Fig. S1 .
MRI experiment
Rats MRI experiments on rats were performed on a 7 T scanner (Bruker, BioSpect 70/30, Ettlingen, Germany) using a receive-only phase array coil with integrated combiner and preamplifier in combination with an actively detuned transmit-only resonator. DW-MRI data were acquired using an 
MRI analysis and statistics
Rat MRI data were processed as follows. Preliminary data were used to verify the reach of a 2µl injection, confirming that the liquid diffused up to 2.6 mm. So, regions of interest (ROIs) for the analysis were manually drawn in the dentate gyrus of the dorsal hippocampus; the injection tract was used to locate the central slice, and ROIs were drawn from two slices before the injection, and up to 2 slices after, for a total length of 3 mm covered.
Raw DW-MRI data were non-linearly registered to the T2-weighted scan to correct for EPI distortions, corrected for motion and eddy current distortions using affine registration, then fed to a custom routine written in Matlab (R2018a, the Mathworks) which fits the signal to a multi-compartment model (MCM) of diffusion The MCM is inspired by the AxCaliber model for white matter [23] but is adapted to grey matter morphology. The model comprises: one compartment of water undergoing restricted diffusion in cylindric geometry (representing water trapped into cell ramifications) with a main orientation and a Watson dispersion term [24] , two spherically restricted compartments [25] , and one extracellular space matrix, aligned with the main cylinder orientation and modelled as a tensor. The fitting parameters are the fraction of water undergoing restricted diffusion in cylinders, the two fraction of water undergoing restricted diffusion in the two spherical compartments, the radii of the two spherical compartments (a smaller and a larger one), and the extra-cellular tensor diffusivity. The MCM is illustrated in Fig. S2 . The low b-value shell was used to fit the conventional tensor model and produce maps of the mean diffusivity. T1 and T2 weighted maps were also used to calculate the T1/T2 ratio, which is considered a proxy for myelination [26] . T2* maps were calculating by fitting an exponential decay to the T2*-weighted images acquired at different echo times. Additionally, for illustration purposes the high-resolution anatomical scans were non-linearly registered to a rat brain template [27] using an advanced normalization approach [28] . Repeated measure ANOVA was used to check for significant effect of the injection and of the group.
Similarly, human MRI data were preprocessed as follows. Motion, eddy current and EPI distortions were corrected using FSL TOPUP and EDDY tools [29] . Correction for gradient nonlinearities [30] [31] , signal drift [32] and Gibbs ringing artefacts [33] was also performed. All diffusion data were then registered to a skull-stripped [34] structural T1-weighted image using EPIREG [27] .
B0 scans were non-linearly registered to a high-resolution human brain template [35] using an advanced normalization approach [28] ; then, the inverse transformation was applied to bring the Desikan GM parcellation in the single subject space. Mean values of all MRI parameters were calculated by averaging the maps in the left and right hippocampi. Both intra and inter-subject coefficient of variations were calculated for each MRI measure.
Tissue processing and immunohistochemistry
Rats were deeply anesthetized with a lethal dose of sodium pentobarbital, 46mg/kg, injected intraperitoneally (Dolethal, E.V.S.A. laboratories., Madrid, España). After, rats were perfused intracardially with 100ml of 0.9% phosphate saline buffer (PBS) and 100ml of ice-cold 4% paraformaldehyde (PFA, BDH, Prolabo, VWR International, Lovaina, Belgium). Then, brains were immediately extracted from the skull and fixed for 1 hour in 4% parafaformaldehyde. Afterwards, brains were included in 3% Agarose/PBS (Sigma-Aldrich, Madrid, Spain), and cut in vibratome (VT 1000S, Leica, Wetzlar, Germany) in 50 μm thick serial coronal sections.
Coronal sections were rinsed and permeabilized three times in 1xPBS with Triton X-100 at 0.5% (Sigma-Aldrich, Madrid, Spain), 10 minutes each one. Then, they were blocked in the same solution with 4% of bovine serum albumin (Sigma-Aldrich, Madrid, Spain) and 2% of goat serum donor herd (Sigma-Aldrich, Madrid, Spain) for 2 hours at room temperature. The slices were then incubated for one night at 4ºC with primary antibodies for Iba-1 (1:1000, Wako Chemicals, Osaka, Japan), GFAP (1:1000, Sigma-
